Back to Directory
Prime.io
Greater London
Founded 2025
CRISPR genome editing and engineered cell models for research
Prime.io is a contract research organisation providing genome editing services and reagents for drug discovery and functional genomics.
Its work includes CRISPR knock-in and knock-out cell line generation, gene editing design, pooled screening and sequencing-based validation. The company develops engineered cellular models using its AI-designed nuclease platform, alongside guide RNAs and donor templates.
Prime.io supports academic and commercial researchers investigating gene function, validating therapeutic targets and developing cellular assays.